Bal Pharma Ltd share price logo

Bal Pharma Ltd Share Price

NSE: BALPHARMA

BSE: 524824

Small Cap

Healthcare Sector

₹71.47

-2.90

(-3.90%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Bal Pharma Ltd Stock Performance

as on December 5, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹70.05
    ₹74
    downward going graph

    1.99%

    Downside

    3.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹70.05
    ₹132
    downward going graph

    1.99%

    Downside

    84.69%

    Upside

    downward going graph

Bal Pharma Ltd share price movements today

Previous Close
₹74.37
Open
₹73.35
Volume
11.11K
Upper Circuit
₹89.24
Lower Circuit
₹59.49
Day's Low - High
₹70.05 - ₹74
52 Week Low - High
₹70.05 - ₹132

Bal Pharma Ltd Historical Returns

1 Month Return
-11.06 %
3 Month Return
-19.8 %
1 Year Return
-42.82 %
3 Year Return
-19.88 %
5 Year Return
+ 23.76 %

Bal Pharma Ltd Fundamentals

as on December 5, 2025 at 4:01 pm IST

Market Cap

₹113.79 Cr

Return on Equity (ROE)

8.14

PE Ratio (TTM)

16.58

Return on capital employed (ROCE)

9.42

Industry PE ratio

42.28

Beta (LTM)

0.64

P/B Ratio

1.34

Dividend Yield

1.44

PEG Ratio

-21.54

Quarterly Earnings Growth YOY

-30.77

EPS (TTM)

4.55

Sector

Pharmaceuticals

Book Value

48.63

Technical Analysis

Bearish

View Technical Analysis

Bal Pharma Ltd Stock Valuation

as on December 5, 2025 at 4:01 pm IST

Bal Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-535.88x)

June 15, 2018

Today (16.58x)

December 5, 2025

Industry (42.28x)

December 5, 2025

Highest (203.65x)

September 12, 2018

LowHigh

Today’s Price to Earnings Ratio: 16.58x

Bal Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bal Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bal Pharma Ltd image
Bal Pharma Ltd
NA113.794.75%0.847303
Oxygenta Pharmaceutical Ltd image
Oxygenta Pharmaceutical Ltd
NA218.39103.41%0.00-10109
Hikal Ltd image
Hikal Ltd
BUY2,997.937.8%0.70901,859
Granules India Ltd image
Granules India Ltd
BUY13,610.088.51%0.645014,481
Concord Drugs Ltd image
Concord Drugs Ltd
NA75.5043.71%0.70145
See all

Bal Pharma Ltd Stock’s Investor Sentiment and Interest

Search interest for Bal Pharma Ltd Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Bal Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
76.62
82.45
70.39
92.54
81.66
94.63
74.36
73.69
73.15
81.88
65.87
74.02
Other Income
0.46
0.19
0.16
0.14
0.1
2.45
0.82
-0.2
0.51
1.08
0.72
1.12
Total Income
77.08
82.64
70.54
92.68
81.76
97.08
75.18
73.49
73.66
82.96
66.59
75.14
Expenses
70.47
74.29
63.94
84.85
73.87
85.03
67.89
66
65.4
74.24
59.81
68.29
Operating Profit
6.15
8.16
6.45
7.69
7.79
9.6
6.47
7.69
7.75
7.64
6.06
5.73
Operating Profit Margin %
8.03%
9.9%
9.16%
8.31%
9.54%
10.14%
8.7%
10.44%
10.59%
9.33%
9.2%
7.74%
Profit Before Interest, Tax and Depreciation
6.61
8.35
6.6
7.84
7.89
12.05
7.28
7.49
8.26
8.72
6.78
6.85
Interest
3.11
3.85
3.64
3.82
3.66
4.14
4.24
3.65
5.01
3.95
4.05
3.86
Depreciation
2.45
2.09
2.53
2.42
2.96
2.16
2.43
2.48
2.69
2.18
2.52
2.27
Profit Before Tax
1.05
2.41
0.43
1.6
1.27
5.75
0.61
1.36
0.56
2.59
0.21
0.72
Tax Paid
0.46
0.79
0.34
0.63
0.42
0.21
0.36
0.32
0.04
-2.82
-
-
Profit After Tax
0.59
1.62
0.09
0.97
0.85
5.53
0.26
1.04
0.52
5.42
0.21
0.72
Total Net profit including share of profit / Loss from associate company
0.59
1.62
0.09
0.97
0.85
5.53
0.26
1.04
0.52
5.42
0.21
0.72
EPS
0.38
1.03
0.06
0.62
0.54
3.73
0.16
0.65
0.33
3.4
0.13
0.45
Actual EPS
0.38
1.03
0.06
0.62
0.54
3.73
0.16
0.65
0.33
3.4
0.13
0.45
Adjusted EPS
0.38
1.03
0.06
0.62
0.54
3.73
0.16
0.65
0.33
3.4
0.13
0.45
Diluted EPS
0.38
1.03
0.06
0.62
0.54
3.74
0.16
0.65
0.33
3.4
0.13
0.45

Bal Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
234.96
211.48
225.01
171.09
250.53
281.21
304.22
339.22
303.08
Other Income
2.97
1.7
1.01
1.85
1.14
5.15
0.98
2.85
2.2
Total Income
237.93
213.18
226.02
172.95
251.67
286.37
305.19
342.07
305.29
Expenses
220.59
194.25
207.5
166.35
226.07
257.74
278.82
308.47
273.52
Operating Profit
14.37
17.23
17.51
4.74
24.46
23.47
25.4
30.75
29.56
Operating Profit Margin %
6.12%
8.15%
7.78%
2.77%
9.76%
8.35%
8.35%
9.06%
9.75%
Profit Before Interest, Tax and Depreciation
17.34
18.93
18.52
6.6
25.6
28.63
26.37
33.6
31.76
Interest
8.49
9.27
12.56
12.45
11.97
10.41
12.49
14.48
16.85
Depreciation
6.49
6.77
6.16
7.68
9.52
9.04
9.13
10.07
9.77
Profit Before Tax
2.36
2.89
-0.2
-13.53
4.11
9.18
4.75
9.05
5.14
Tax Paid
3.1
2.51
-2.36
-0.64
-0.61
3.48
2.13
1.61
-2.1
Profit After Tax
-0.74
0.38
2.15
-12.89
4.71
5.7
2.62
7.45
7.24
Total Net profit including share of profit / Loss from associate company
-0.74
0.38
2.15
-12.89
4.71
5.7
2.62
7.45
7.24
EPS
-0.52
0.27
1.52
-8.62
3.34
3.79
1.67
4.94
4.56
Actual EPS
-0.52
0.27
1.52
-8.62
3.34
3.79
1.67
4.94
4.56
Adjusted EPS
-0.52
0.27
1.52
-8.62
3.34
3.79
1.67
4.94
4.56
Diluted EPS
-0.52
0.27
1.52
-8.62
3.34
3.79
1.68
4.96
4.56

Bal Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-19.35
6.31
0.58
7.76
23.24
22.34
26.8
-1.54
22.81
20.32
Cash Flow from Investing Activities
-13.88
-7.96
-3.56
-8.04
0.22
-2.18
-9.48
-22.19
-18.89
-14.92
Cash Flow from Financing Activities
32.37
-5.94
3.54
0.01
-19.98
-16.63
-17.22
24.09
-1.21
-7.84
Net Cash Flow
-0.86
-7.58
0.55
-0.27
-1.58
0.16
0.09
0.37
2.71
-2.44

Bal Pharma Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Bal Pharma Ltd.

  • Bal Pharma Ltd Earnings Results

    Bal Pharma Ltd’s net profit fell -31.73% since last year same period to ₹0.71Cr in the Q2 2025-2026. On a quarterly growth basis, Bal Pharma Ltd has generated 255% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Bal Pharma Ltd Dividends May,2025

    In the quarter ending March 2025, Bal Pharma Ltd has declared dividend of ₹1.20 per share on 29 May 2025 - translating a dividend yield of 1.68%.

    Read More about Dividends

Insights on Bal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.15% to 0.22% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 66.59 Cr → 75.14 Cr (in ₹), with an average increase of 11.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.2 Cr → 0.71 Cr (in ₹), with an average increase of 71.8% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.86% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 13.6% return, outperforming this stock by 56.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 134.4% return, outperforming this stock by 154.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BALPHARMA stock has moved down by -5.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 48.99% to 48.92% in Sep 2025 quarter

About Bal Pharma Ltd

BPL, a member of Macrolabs group, was incorporated in May 1987 and took over a pharmaceutical product manufacturing unit in Bangalore worth Rs 25.18 lac. The company manufactures and markets, pharmaceutical formulations such as paracetamol, aluminium hydroxide and povidone iodine. It came out with a public issue in Feb 1995 for the manufacturing of bulk drugs and expansion of pharmaceutical formulations. Additions to product range include AZIWIN CAFIMOL, CORTIDERM, Zanovid, Aziwin Dry Syrup, Meloxi Ocium, M Progit, MPS and Cardiac Specialities, AmilorideBenzydamine and Ebastine were added in 2002. BPL promotes its products through the sales force of the Macrolabs group and plans to launch its own soon. The unit has become a division of Bal Pharma Limited, thus marking an expansion in the drug production.

Revenue: ₹74.02Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.72Cr as on September 2025 (Q2 FY26)
Listing date: 08 May, 2006
OrganisationBal Pharma Ltd
HeadquartersBangalore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Bal Pharma Ltd share price today?

Bal Pharma Ltd share price today stands at ₹71.47 as on at the close of the market. Bal Pharma Ltd share today touched a day high of ₹74 and a low of ₹70.05.

What is the 52 week high and 52 week low range for Bal Pharma Ltd share?

Bal Pharma Ltd touched a 52 week high of ₹132 and a 52 week low of ₹70.05. Bal Pharma Ltd share price today i.e. is closed at ₹71.47, which is -45.86% down from its 52 week high and 2.03% up from its 52 week low.

What is Bal Pharma Ltd's market capitalisation today?

Bal Pharma Ltd market capitalisation is ₹113.79 Cr as on .

How to buy Bal Pharma Ltd shares?

To buy Bal Pharma Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BALPHARMA or Bal Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bal Pharma Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bal Pharma Ltd trading volume today?

Bal Pharma Ltd trading volume is 11.11K as on . This means that 11.11K shares of Bal Pharma Ltd were bought and sold on the stock market during today's trading session.